Paper24670080
Rituximab (Rituxan) therapy for severe thyroid-associated ophthalmopathy diminishes IGF-1R(+) T cells.
McCoy AN and 5 others. J Clin Endocrinol Metab, 2014. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Rituximab (Rituxan) therapy for severe thyroid-associated ophthalmopathy diminishes IGF-1R(+) T cells. Papers, record 24670080. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24670080
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Monoclonal, Murine-Derived | Major topic |
| Graves Ophthalmopathy | Major topic |
| Receptor, IGF Type 1 | Major topic |
| T-Lymphocytes | Major topic |
| Aged | |
| Dose-Response Relationship, Drug | |
| Female | |
| Humans | |
| Lymphocyte Count | |
| Male | |
| Middle Aged | |
| Retrospective Studies | |
| Rituximab | |
| Severity of Illness Index | |
| Treatment Outcome |
Source PubMed
Grants11
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 EY021197 | NEI NIH HHS | United States | R01EY021197 | PubMed and NIH | NIH RePORTER |
| EY007003 | NEI NIH HHS | United States | PubMed | PubMed | |
| EY021197 | NEI NIH HHS | United States | R01EY021197 | PubMed and NIH | NIH RePORTER |
| R01 EY011708 | NEI NIH HHS | United States | R01EY011708 | PubMed and NIH | NIH RePORTER |
| EY011708 | NEI NIH HHS | United States | R01EY011708 | PubMed and NIH | NIH RePORTER |
| P30 EY007003 | NEI NIH HHS | United States | P30EY007003 | PubMed | NIH RePORTER |
| EY008976 | NEI NIH HHS | United States | R01EY008976 | PubMed and NIH | NIH RePORTER |
| R01 DK063121 | NIDDK NIH HHS | United States | R01DK063121 | PubMed and NIH | NIH RePORTER |
| R01 EY008976 | NEI NIH HHS | United States | R01EY008976 | PubMed and NIH | NIH RePORTER |
| F31 EY007003 | NEI NIH HHS | United States | F31EY007003 | PubMed | NIH RePORTER |
| DK063121 | NIDDK NIH HHS | United States | R01DK063121 | PubMed and NIH | NIH RePORTER |
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12794168 | Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway. | J Immunol | 2003 | https://conductscience.org/library/papers/12794168 | PubMed |
| 2 | 21677036 | Autoimmunity in Graves' ophthalmopathy: the result of an unfortunate marriage between TSH receptors and IGF-1 receptors? | J Clin Endocrinol Metab | 2011 | https://conductscience.org/library/papers/21677036 | PubMed |
| 3 | 17312178 | Aberrant expression of the insulin-like growth factor-1 receptor by T cells from patients with Graves' disease may carry functional consequences for disease pathogenesis. | J Immunol | 2007 | https://conductscience.org/library/papers/17312178 | PubMed |
| 4 | 14575864 | IGF-I stimulates IL-8 production in the promyelocytic cell line HL-60 through activation of extracellular signal-regulated protein kinase. | Cell Signal | 2003 | https://conductscience.org/library/papers/14575864 | PubMed |
| 5 | 17284622 | B lymphocyte depletion with the monoclonal antibody rituximab in Graves' disease: a controlled pilot study. | J Clin Endocrinol Metab | 2007 | https://conductscience.org/library/papers/17284622 | PubMed |
| 6 | 18768899 | Evidence for an association between thyroid-stimulating hormone and insulin-like growth factor 1 receptors: a tale of two antigens implicated in Graves' disease. | J Immunol | 2008 | https://conductscience.org/library/papers/18768899 | PubMed |
| 7 | 15277570 | Insulin-like growth factor-I stimulates IL-10 production in human T cells. | J Leukoc Biol | 2004 | https://conductscience.org/library/papers/15277570 | PubMed |
| 8 | 19785644 | Evidence of orbital B and T cell depletion after rituximab therapy in Graves' ophthalmopathy. | Acta Ophthalmol | 2009 | https://conductscience.org/library/papers/19785644 | PubMed |
| 9 | 19818507 | Rituximab treatment of patients with severe, corticosteroid-resistant thyroid-associated ophthalmopathy. | Ophthalmology | 2010 | https://conductscience.org/library/papers/19818507 | PubMed |
| 10 | 18832736 | B cells from patients with Graves' disease aberrantly express the IGF-1 receptor: implications for disease pathogenesis. | J Immunol | 2008 | https://conductscience.org/library/papers/18832736 | PubMed |
| 11 | 8126135 | Effect of growth hormone and insulin-like growth factor-I on immunoglobulin production by and growth of human B cells. | J Clin Endocrinol Metab | 1994 | https://conductscience.org/library/papers/8126135 | PubMed |
| 12 | 16914591 | Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers. | Eur J Endocrinol | 2006 | https://conductscience.org/library/papers/16914591 | PubMed |
| 13 | 8046348 | Growth hormone and insulin-like growth factor I induce immunoglobulin (Ig)E and IgG4 production by human B cells. | J Exp Med | 1994 | https://conductscience.org/library/papers/8046348 | PubMed |
| 14 | 19897675 | Increased generation of fibrocytes in thyroid-associated ophthalmopathy. | J Clin Endocrinol Metab | 2010 | https://conductscience.org/library/papers/19897675 | PubMed |
| 15 | 17822379 | The thyrotropin receptor in Graves' disease. | Thyroid | 2007 | https://conductscience.org/library/papers/17822379 | PubMed |
| 16 | 17218723 | Treatment of Graves' disease and associated ophthalmopathy with the anti-CD20 monoclonal antibody rituximab: an open study. | Eur J Endocrinol | 2007 | https://conductscience.org/library/papers/17218723 | PubMed |
| 17 | 7517705 | Autoantibodies to IGF-1 binding sites in thyroid associated ophthalmopathy. | Autoimmunity | 1993 | https://conductscience.org/library/papers/7517705 | PubMed |
| 18 | 8306510 | Immunological effects of insulin-like growth factor-I--enhancement of immunoglobulin synthesis. | Clin Exp Immunol | 1994 | https://conductscience.org/library/papers/8306510 | PubMed |
| 19 | 18085668 | Levels of autoantibodies, unlike antibodies to all extrinsic antigen groups, fall following B cell depletion with Rituximab. | Eur J Immunol | 2008 | https://conductscience.org/library/papers/18085668 | PubMed |
| 20 | 20392809 | Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases? | Pharmacol Rev | 2010 | https://conductscience.org/library/papers/20392809 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41728592 | The therapeutic revolution in thyroid eye disease: from orbital radiotherapy to teprotumumab and AI. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/41728592 | PubMed |
| 41555141 | Elevated IGF1R and abnormal methylated IGF1R in immune thrombocytopenia. | Ann Hematol | 2026 | https://conductscience.org/library/papers/41555141 | PubMed |
| 40950996 | Hepatic tuberculosis induced by rituximab treatment for C1q nephropathy with minimal change disease: a case report. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/40950996 | PubMed |
| 40404973 | Comparative efficacy and safety of rituximab, tocilizumab, and teprotumumab in Graves' orbitopathy: a systematic review and meta-analysis. | Eye (Lond) | 2025 | https://conductscience.org/library/papers/40404973 | PubMed |
| 39039206 | Graves disease: latest understanding of pathogenesis and treatment options. | Nat Rev Endocrinol | 2024 | https://conductscience.org/library/papers/39039206 | PubMed |
| 38642306 | CD20 + T lymphocytes in isolated Hashimoto's thyroiditis and type 3 autoimmune polyendocrine syndrome: a pilot study. | J Endocrinol Invest | 2024 | https://conductscience.org/library/papers/38642306 | PubMed |
| 37108173 | Prostaglandin F2α Regulates Adipogenesis by Modulating Extracellular Signal-Regulated Kinase Signaling in Graves' Ophthalmopathy. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37108173 | PubMed |
| 35604323 | Current concepts regarding Graves' orbitopathy. | J Intern Med | 2022 | https://conductscience.org/library/papers/35604323 | PubMed |
| 33868176 | Mechanisms That Underly T Cell Immunity in Graves' Orbitopathy. | Front Endocrinol (Lausanne) | 2021 | https://conductscience.org/library/papers/33868176 | PubMed |
| 31919775 | Thyroid eye disease: current and potential medical management. | Int Ophthalmol | 2020 | https://conductscience.org/library/papers/31919775 | PubMed |
| 29736194 | Thyroid-Associated Orbitopathy and Biomarkers: Where We Are and What We Can Hope for the Future. | Dis Markers | 2018 | https://conductscience.org/library/papers/29736194 | PubMed |
| 29452583 | Does rituximab improve clinical outcomes of patients with thyroid-associated ophthalmopathy? A systematic review and meta-analysis. | BMC Ophthalmol | 2018 | https://conductscience.org/library/papers/29452583 | PubMed |
| 28702253 | Update on thyroid-associated Ophthalmopathy with a special emphasis on the ocular surface. | Clin Diabetes Endocrinol | 2016 | https://conductscience.org/library/papers/28702253 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| IGF1R | 3480 | PubTator's text mining | https://conductscience.org/library/genes/3480 | NCBI Gene |
| KRT20 | 54474 | PubTator's text mining | https://conductscience.org/library/genes/54474 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24670080
GET https://conductscience.org/api/papers/v1/24670080/references?page=2